Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Urolithiasis. 2015 Oct 14;44(3):241–246. doi: 10.1007/s00240-015-0827-8

Clinical, demographic, and laboratory characteristics of children with nephrolithiasis

David J Sas a, Lauren J Becton b, Jeffrey Tutman c, Laura A Lindsay d, Amy H Wahlquist e
PMCID: PMC5215772  NIHMSID: NIHMS833036  PMID: 26467033

Abstract

While the incidence of pediatric kidney stones appears to be increasing, little is known about the demographic, clinical, laboratory, imaging, and management variables in this patient population. We sought to describe various characteristics of our stone-forming pediatric population. To that end, we retrospectively reviewed the charts of pediatric patients with nephrolithiasis confirmed by imaging. Data were collected on multiple variables from each patient and analyzed for trends. For body mass index (BMI) controls, data from the general pediatrics population similar to our nephrolithiasis population were used. Data on 155 pediatric nephrolithiasis patients were analyzed. Of the 54 calculi available for analysis, 98% were calcium-based. Low urine volume, elevated supersaturation of calcium phosphate, elevated supersaturation of calcium oxalate, and hypercalciuria were the most commonly identified abnormalities on analysis of 24-hour urine collections. Our stone-forming population did not have a higher BMI than our general pediatrics population, making it unlikely that obesity is a risk factor for nephrolithiasis in children. More girls presented with their first stone during adolescence, suggesting a role for reproductive hormones contributing to stone risk, while boys tended to present more commonly at a younger age, though this did not reach statistical significance. These intriguing findings warrant further investigation.

Keywords: nephrolithiasis, urolithiasis, kidney stones, pediatrics, obesity, adolescents

Introduction

Nephrolithiasis in children is increasingly more common and accounts for a growing proportion of pediatric hospitalizations and cost [14]. It is associated with considerable pain in all age groups, and elevated blood pressure and decreased renal function in studies of adult cohorts [58]. Additionally, younger patients may have a lower rate of spontaneous passage for calculi and may be more likely to require invasive and costly surgical intervention [9].

While there has been much speculation regarding the cause of the increasing incidence of pediatric nephrolithiasis, there have not yet been any conclusive answers. Possible reasons for the increasing incidence have included obesity, increased sodium intake, decreased calcium intake, decreased water intake, and increased antibiotic usage [10].

We set forth to analyze data from our growing population of pediatric stone formers from our single institution in the so-called “stone belt” to look for patterns related to clinical, demographic or laboratory data. We specifically sought to compare our stone-forming population to our general pediatric population with regards to obesity.

Materials and Methods

This study was approved by the institutional review board of the Medical University of South Carolina (MUSC). We identified patients in our electronic medical record with International Classification of Diseases, 9th Edition (ICD-9) code 592.0 (nephrolithiasis) or 592.9 (urolithiasis) between the ages of 0 and 18 years. Of the 200 patients identified, 155 had kidney stones confirmed by imaging studies (CT, ultrasound, or abdominal x-ray). We retrospectively reviewed the charts of these 155 patients and collected data on demographic, clinical, laboratory, evaluation, management and follow-up variables on each patient. Data regarding 24-hour urine chemistry analysis were based on pediatric norms established by Litholink or other reference ranges (see Supplemental Table 1) [1115]. Collection adequacy for 24-hour urine collections was validated by urine creatinine excretion rate.

As controls for body mass index (BMI), we used data collected from well-child checks in general pediatric patients from 14 pediatric primary care clinics in South Carolina, which provide a similar broad geographic representation of children as our stone forming population. Overweight is defined as BMI between 85th and 94th percentile for age and gender and obese is defined as BMI >95th percentile for age and gender. Data from 132 subjects with kidney stones with complete weight and height data and 947 controls were included in the analyses. Logistic regression models that were used to determine the relationships between variables of interest (gender, BMI, age) and whether someone was a stone former or control patient. Interaction terms with BMI were included (gender by BMI, age by BMI) to determine if these relationships impacted prediction of someone being a stone former. Contrast statements were also used to compare individuals’ levels of potential predictor variables between stone formers and controls instead of the overall effect of the variable of interest. Funding for the statistical analysis was provided by SCTR Grant UL1 RR029882.

Results

We analyzed data from 155 subjects who had kidney stones confirmed by imaging studies between 1993 and 2010. Eight patients were seen prior to the year 2000, 56 from 2000 through 2004, and 91 from 2005 through 2010. Forty-eight percent were girls and 52% boys. Mean and median follow-up times were 18 and 12 months respectively (range 0–78 months). Based on zip code of residence, 26.5% of our subjects live in rural areas vs. 23.6% of the general pediatric population. Of the 62.5% who had a positive family history for kidney stones, 58% had at least one 1st degree relative with stones.

Regarding relevant medical history, 9 subjects were born prematurely (range 23–36 weeks gestation), 3 had vesicoureteral reflux, 3 had neurogenic bladder, and 2 had medullary sponge kidney. Just over half of our subjects presented initially with back/flank pain and 1/3 presented with gross hematuria, vomiting, and/or abdominal pain. At presentation, only 12% had dysuria and 7% had fever. Boys most commonly presented in the 6–11 year age range while girls most commonly presented during adolescence (Fig. 1), though these differences were not statistically different.

Fig. 1.

Fig. 1

Age of initial presentation by age range. Boys most commonly present with their first kidney stone during 6–11 years of age while girls most commonly present during adolescence.

The mean (SD) of BMI percentiles (based on age and gender) for the stone formers was 51.4 (34.8), and the mean (SD) of BMI percentiles for the control population was 62.7 (31.1) (p<0.001). Stone formers have a lower BMI than controls in all age groups and are less likely to be overweight than controls (Fig. 2). When divided by gender, girl stone formers are more likely to have a BMI in the normal range than boys (Fig. 3).

Fig. 2.

Fig. 2

Percent of stone formers and controls who are overweight or obese by age group. A smaller percentage of stone formers are overweight or obese compared with controls in all age ranges.

Fig. 3.

Fig. 3

Percent of girl and boy stone formers and controls who are underweight (<5th percentile BMI), normal (5–84th percentile BMI) and overweight or obese (≥85th percentile BMI). Girl stone formers are less likely to be overweight or obese than boy stone formers.

Stone analysis was performed on the 54 stones available from 53 different subjects. Analysis revealed that 98% of stones contained calcium with the majority being predominantly calcium oxalate (Table 1). Adequacy of 24-hour urine collection was 76% overall and 94% if performed through Litholink vs. 67% if performed through the hospital lab. The most common metabolic abnormalities found in 24-hour urine samples were high calcium phosphate supersaturation (57%), low urine volume (53%), high calcium oxalate supersaturation (39%), and hypercalciuria (34%). Hyperoxaluria and hypocitraturia were found in 18% and 15% of subjects respectively (Fig. 4). Mean 24-hour urine sodium excretion was 135.2 mmol/day (3.97 mmol/kg). Potassium excretion was below the reference range (> 3 mEq/kg/day) in 24% of patients and magnesium excretion was below the reference range (> 88 mg/1.73m2/day) in 9% of patients. Selected excretion data are displayed in Table 2.

Table 1.

Stone composition from 54 kidney stones. Calcium was a component of 98% of stones.

# %
Calcium Oxalate (pure) 31 57.4
Calcium Phosphate (pure) 3 5.6
Calcium Oxalate-Calcium Phosphate mix 16 29.6
Calcium Oxalate-Calcium Phosphate-Uric Acid mix 1 1.9
Ammonium Magnesium Phosphate-Calcium Phosphate mix 2 3.7
Cystine 1 1.9
Uric Acid (pure) 0 0.0
TOTAL 54

Fig. 4.

Fig. 4

Percentage of specific abnormalities in 24-hour urine chemistry. SS=supersaturation, Ca=calcium, Ox = oxalate, P=phosphate, Citr=hypocitraturia, UA=uric acid.

Table 2.

Excretion rates of calcium, oxalate, citrate, and magnesium.

1st quartile 2nd quartile 3rd quartile 4th quartile Median
Calcium (mg/kg/24 hours) 0.6–1.5 1.6–2.3 2.4–4.2 4.3–9.3 2.4
Oxalate (mg/1.73m2/24 hours) 17.0–28.4 28.5–40.4 40.5–46.8 46.9–121.5 40.5
Citrate (mg/mg creat/24 hours) 42.9–452.4 452.5–611.8 611.9–735.3 735.4–1614.2 611.9
Magnesium (mg/1.73m2/24 hours) 22.3–101.0 101.1–112.5 112.6–128.9 129.0–203.9 112.6

At initial presentation, 41% of subjects had a CT scan and 43% had an ultrasound. Thirty-two percent of subjects had more than one CT scan. Stone sizes based on imaging ranged from 0.5 mm to 25 mm, though there were also subjects in whom small stones were described as “tiny” or “punctate” with no numerical value given. Twenty (13%) of our subjects had congenital abnormalities of the urinary tract (11 males, 9 females). Overall, 29% of our subjects had a urological procedure performed. Of those, 29% had extracorporeal shock wave lithotripsy (ESWL), 40% had ureteroscopic extraction without laser, and 31% had ureteroscopic extraction with laser. Twenty seven percent were admitted to the hospital with an average length-of-stay of 4.2 days. Regarding recurrence of kidney stones, 53% of our patients did not have a recurrence, 27.5% had 1–3 episodes of recurrence, and 19.5% had >3 episodes of recurrence.

Discussion

These data representing the largest pediatric stone-forming population published in two decades [16] provide information regarding demographic, clinical, and laboratory characteristics of pediatric kidney stone formers and improve our fund of knowledge regarding the role of obesity and gender, highlighting the need for definitive prospective research. The results suggest that obesity is not a contributing factor to the increasing incidence of kidney stones in children. These data also support the notion that some gender differences may be relevant in determining underlying causes of increasing incidence of pediatric nephrolithiasis.

Our data suggest that obesity is not a risk factor for pediatric nephrolithiasis. In fact, our pediatric stone formers have a lower BMI on average than our general pediatric population. While adult nephrolithiasis literature suggests that higher BMI increases risk for nephrolithiasis[17,18], pediatric studies examining the relationship between higher BMI and risk for kidney stones in children have been mixed [19,20]. To further complicate matters, the two studies performed to describe urinary stone risk factors related to BMI in children ended up with widely varying (in the case of oxalate excretion, completely opposite) results [21,22].

Given the paucity of data, one must rely on the notion of biological plausibility when contemplating a potential increase in risk for nephrolithiasis in pediatric patients who are obese. While there are data showing that obese adults have a lower urine pH [17], the relationship between BMI and pH may be opposite in children [22]. Indeed, in adults higher BMI may be associated with higher risk only for uric acid stones but not calcium-based stones [23]. But uric acid stones are more common in adults than in pediatrics; we have not had any pure uric acid stone formers in our pediatric population. Our data are consistent with most pediatric literature on obesity and stones showing no direct relationship between higher BMI and pediatric nephrolithiasis.

Perhaps the most compelling finding is related to gender differences in our pediatric stone-forming population. While boys more commonly present prior to adolescence, girls present most commonly during pubertal years. Though our findings regarding the rate of kidney stone formation between genders did not reach statistical significance, it is consistent with other recent publications [2,24,3]. This, combined with evidence of a decline in the male-predominance of kidney stone disease in the adult population [25], provokes compelling questions regarding hormonal influences versus some constellation of environmental factors contributing to this intriguing shift.

While Maalouf et al provided evidence that estrogen supplementation increases the risk for kidney stones in post-menopausal women [26], other studies demonstrate an inhibitory effect of female reproductive hormones [27,28]. Additionally, data regarding the potential mechanisms are inconsistent [29,30]. There are no published data regarding the effect of reproductive hormones on nephrolithiasis risk or risk factors in adolescents, but the increase in kidney stones in our adolescent female population suggests that investigation is warranted.

The urine chemistry results from our population were comparable to other previously-reported populations [13,31,32]. Like most stone-forming children, our population demonstrates a combination of low urinary volume, hypercalciuria, hyperoxaluria, and hypocitraturia leading to elevated supersaturation of calcium phosphate and/or calcium oxalate.

The primary limitation of our study is that it is retrospective in nature, resulting in a lack of uniform data. Additionally, like all pediatric kidney stone studies to date, we have a relatively small sample size. Lastly, because these data come from one geographic area, it is not certain that our findings can be extrapolated to the entire U.S. pediatric population. These limitations support the formation of a national kidney stone registry which will allow for uniform collection of data from multiple institutions, which may provide more insight into the risk factors contributing to pediatric nephrolithiasis and provide a matrix to test potential therapeutic interventions.

Conclusions

While the causes related to the increasing incidence of kidney stone in children are not yet known, obesity is not a likely contributor. The increasing incidence in the adolescent female population suggests a role for reproductive hormones contributing to stone risk which warrants further investigation.

Supplementary Material

Acknowledgments

Funding for the statistical analysis was provided by SCTR Grant UL1 RR029882.

Footnotes

Conflict of Interest Statement: None of the authors have any conflicts of interest to declare.

References

  • 1.Bush NC, Xu L, Brown BJ, Holzer MS, Gingrich A, Schuler B, Tong L, Baker LA. Hospitalizations for pediatric stone disease in United States, 2002–2007. J Urol. 2010;183(3):1151–1156. doi: 10.1016/j.juro.2009.11.057. doi:S0022-5347(09)02948-6 [pii] 10.1016/j.juro.2009.11.057. [DOI] [PubMed] [Google Scholar]
  • 2.Dwyer ME, Krambeck AE, Bergstralh EJ, Milliner DS, Lieske JC, Rule AD. Temporal trends in incidence of kidney stones among children: a 25-year population based study. J Urol. 2012;188(1):247–252. doi: 10.1016/j.juro.2012.03.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Routh JC, Graham DA, Nelson CP. Epidemiological trends in pediatric urolithiasis at United States freestanding pediatric hospitals. J Urol. 2010;184(3):1100–1104. doi: 10.1016/j.juro.2010.05.018. doi:S0022-5347(10)03537-8 [pii] 10.1016/j.juro.2010.05.018. [DOI] [PubMed] [Google Scholar]
  • 4.Sas DJ, Hulsey TC, Shatat IF, Orak JK. Incidence of kidney stones in children evaluated in the ER is increasing. Journal of Pediatrics. 2010 doi: 10.1016/j.jpeds.2010.02.004. [DOI] [PubMed] [Google Scholar]
  • 5.Gillen DL, Coe FL, Worcester EM. Nephrolithiasis and increased blood pressure among females with high body mass index. Am J Kidney Dis. 2005;46(2):263–269. doi: 10.1053/j.ajkd.2005.04.030. doi:S0272-6386(05)00604-9 [pii] 10.1053/j.ajkd.2005.04.030. [DOI] [PubMed] [Google Scholar]
  • 6.Gillen DL, Worcester EM, Coe FL. Decreased renal function among adults with a history of nephrolithiasis: a study of NHANES III. Kidney Int. 2005;67(2):685–690. doi: 10.1111/j.1523-1755.2005.67128.x. doi:KID67128 [pii] 10.1111/j.1523-1755.2005.67128.x. [DOI] [PubMed] [Google Scholar]
  • 7.Rule AD, Bergstralh EJ, Melton LJ, 3rd, Li X, Weaver AL, Lieske JC. Kidney stones and the risk for chronic kidney disease. Clinical journal of the American Society of Nephrology: CJASN. 2009;4(4):804–811. doi: 10.2215/CJN.05811108. doi:CJN.05811108 [pii] 10.2215/CJN.05811108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Worcester EM, Parks JH, Evan AP, Coe FL. Renal function in patients with nephrolithiasis. J Urol. 2006;176(2):600–603. doi: 10.1016/j.juro.2006.03.095. discussion 603. doi:S0022-5347(06)00780-4 [pii] 10.1016/j.juro.2006.03.095. [DOI] [PubMed] [Google Scholar]
  • 9.Pietrow PK, Pope JCt, Adams MC, Shyr Y, Brock JW., 3rd Clinical outcome of pediatric stone disease. J Urol. 2002;167(2 Pt 1):670–673. doi: 10.1016/S0022-5347(01)69121-3. [DOI] [PubMed] [Google Scholar]
  • 10.Sas DJ. An update on the changing epidemiology and metabolic risk factors in pediatric kidney stone disease. Clinical journal of the American Society of Nephrology: CJASN. 2011;6(8):2062–2068. doi: 10.2215/CJN.11191210. [DOI] [PubMed] [Google Scholar]
  • 11.Battino BS, De FW, Coe F, Tackett L, Erhard M, Wacksman J, Sheldon CA, Minevich E. Metabolic evaluation of children with urolithiasis: are adult references for supersaturation appropriate? J Urol. 2002;168(6):2568–2571. doi: 10.1016/S0022-5347(05)64217-6. doi:S0022-5347(05)64217-6 [pii] [DOI] [PubMed] [Google Scholar]
  • 12.Matos V, Van Melle G, Werner D, Bardy D, Guignard JP. Urinary oxalate and urate to creatinine ratios in a healthy pediatric population. American journal of kidney diseases: the official journal of the National Kidney Foundation. 1999;34(2):e1. doi: 10.1053/AJKD034000e6. [DOI] [PubMed] [Google Scholar]
  • 13.Penido MG, Srivastava T, Alon US. Pediatric primary urolithiasis: 12-year experience at a Midwestern Children’s Hospital. J Urol. 2013;189(4):1493–1497. doi: 10.1016/j.juro.2012.11.107. [DOI] [PubMed] [Google Scholar]
  • 14.Alon US. Medical treatment of pediatric urolithiasis. Pediatric nephrology. 2009;24(11):2129–2135. doi: 10.1007/s00467-007-0740-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Matos V, van Melle G, Boulat O, Markert M, Bachmann C, Guignard JP. Urinary phosphate/creatinine, calcium/creatinine, and magnesium/creatinine ratios in a healthy pediatric population. The Journal of pediatrics. 1997;131(2):252–257. doi: 10.1016/s0022-3476(97)70162-8. [DOI] [PubMed] [Google Scholar]
  • 16.Milliner DS, Murphy ME. Urolithiasis in pediatric patients. Mayo Clin Proc. 1993;68(3):241–248. doi: 10.1016/s0025-6196(12)60043-3. [DOI] [PubMed] [Google Scholar]
  • 17.Maalouf NM, Sakhaee K, Parks JH, Coe FL, Adams-Huet B, Pak CY. Association of urinary pH with body weight in nephrolithiasis. Kidney Int. 2004;65(4):1422–1425. doi: 10.1111/j.1523-1755.2004.00522.x. [DOI] [PubMed] [Google Scholar]
  • 18.Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA. 2005;293(4):455–462. doi: 10.1001/jama.293.4.455. doi:293/4/455 [pii] 10.1001/jama.293.4.455. [DOI] [PubMed] [Google Scholar]
  • 19.Ayoob R, Wang W, Schwaderer A. Body fat composition and occurrence of kidney stones in hypercalciuric children. Pediatr Nephrol. 2011;26(12):2173–2178. doi: 10.1007/s00467-011-1927-5. [DOI] [PubMed] [Google Scholar]
  • 20.Kim SS, Luan X, Canning DA, Landis JR, Keren R. Association between body mass index and urolithiasis in children. J Urol. 2011;186(4 Suppl):1734–1739. doi: 10.1016/j.juro.2011.04.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Eisner BH, Eisenberg ML, Stoller ML. Influence of Body Mass Index on Quantitative 24-Hour Urine Chemistry Studies in Children With Nephrolithiasis. J Urol. 2009 doi: 10.1016/j.juro.2009.05.052. doi:S0022-5347(09)01207-5 [pii] 10.1016/j.juro.2009.05.052. [DOI] [PubMed] [Google Scholar]
  • 22.Sarica K, Eryildirim B, Yencilek F, Kuyumcuoglu U. Role of overweight status on stone-forming risk factors in children: a prospective study. Urology. 2009;73(5):1003–1007. doi: 10.1016/j.urology.2008.11.038. doi:S0090-4295(08)01945-6 [pii] 10.1016/j.urology.2008.11.038. [DOI] [PubMed] [Google Scholar]
  • 23.Daudon M, Lacour B, Jungers P. Influence of body size on urinary stone composition in men and women. Urol Res. 2006;34(3):193–199. doi: 10.1007/s00240-006-0042-8. [DOI] [PubMed] [Google Scholar]
  • 24.Novak TE, Lakshmanan Y, Trock BJ, Gearhart JP, Matlaga BR. Sex prevalence of pediatric kidney stone disease in the United States: an epidemiologic investigation. Urology. 2009;74(1):104–107. doi: 10.1016/j.urology.2008.12.079. doi:S0090-4295(09)00231-3 [pii] 10.1016/j.urology.2008.12.079. [DOI] [PubMed] [Google Scholar]
  • 25.Scales CD, Jr, Curtis LH, Norris RD, Springhart WP, Sur RL, Schulman KA, Preminger GM. Changing gender prevalence of stone disease. J Urol. 2007;177(3):979–982. doi: 10.1016/j.juro.2006.10.069. doi:S0022-5347(06)02731-5 [pii] [pii] 10.1016/j.juro.2006.10.069. [DOI] [PubMed] [Google Scholar]
  • 26.Maalouf NM, Sato AH, Welch BJ, Howard BV, Cochrane BB, Sakhaee K, Robbins JA. Postmenopausal hormone use and the risk of nephrolithiasis: results from the Women’s Health Initiative hormone therapy trials. Archives of internal medicine. 2010;170(18):1678–1685. doi: 10.1001/archinternmed.2010.342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Fan J, Chandhoke PS, Grampsas SA. Role of sex hormones in experimental calcium oxalate nephrolithiasis. J Am Soc Nephrol. 1999;10(Suppl 14):S376–380. [PubMed] [Google Scholar]
  • 28.Iguchi M, Takamura C, Umekawa T, Kurita T, Kohri K. Inhibitory effects of female sex hormones on urinary stone formation in rats. Kidney Int. 1999;56(2):479–485. doi: 10.1046/j.1523-1755.1999.00586.x. [DOI] [PubMed] [Google Scholar]
  • 29.Dey J, Creighton A, Lindberg JS, Fuselier HA, Kok DJ, Cole FE, Hamm L. Estrogen replacement increased the citrate and calcium excretion rates in postmenopausal women with recurrent urolithiasis. J Urol. 2002;167(1):169–171. [PubMed] [Google Scholar]
  • 30.Heller HJ, Sakhaee K, Moe OW, Pak CY. Etiological role of estrogen status in renal stone formation. J Urol. 2002;168(5):1923–1927. doi: 10.1097/01.ju.0000033907.21910.be. [DOI] [PubMed] [Google Scholar]
  • 31.Spivacow FR, Negri AL, del Valle EE, Calvino I, Fradinger E, Zanchetta JR. Metabolic risk factors in children with kidney stone disease. Pediatr Nephrol. 2008;23(7):1129–1133. doi: 10.1007/s00467-008-0769-2. [DOI] [PubMed] [Google Scholar]
  • 32.VanDervoort K, Wiesen J, Frank R, Vento S, Crosby V, Chandra M, Trachtman H. Urolithiasis in pediatric patients: a single center study of incidence, clinical presentation and outcome. J Urol. 2007;177(6):2300–2305. doi: 10.1016/j.juro.2007.02.002. doi:S0022-5347(07)00318-7 [pii] 10.1016/j.juro.2007.02.002. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

RESOURCES